Morepen Labs lands record Rs. 825 crore global CDMO contract
This multi-year CDMO agreement involves significant, ongoing manufacturing for a global pharmaceutical major
This multi-year CDMO agreement involves significant, ongoing manufacturing for a global pharmaceutical major
The agreement ensures BIOEMTECH customers can consistently obtain Ac-225 for preclinical studies
The trial targeted a patient population with high BMI and extensive skin involvement, averaging over 39 kg/m²
40+ most innovative startups with disruptive contributions across MedTech, Medical Devices, BioPharma, Cell and Gene Therapy, AI and ML, Nutraceuticals, and Biomarkers exhibited their cutting-edge solutions
ANYRA is India’s first indigenously developed Aflibercept 2 mg biosimilar
Each company will share operational data with Evinova, feeding the platform’s AI engines to provide benchmarks and actionable insights, aiming to speed up trials while maintaining top-tier patient care
Dr Adams’ lab recently uncovered a novel cellular detoxification pathway driving Cisplatin resistance in NSCLC
Subscribe To Our Newsletter & Stay Updated